Blocking PRMT5 might force resistant brain-tumor cells into senescence, study suggests

Blocking an enzyme called PRMT5 in tumor cells could be a promising new strategy for the treatment of glioblastoma, the most aggressive and lethal form of brain cancer, a new study suggests.